Anesth Analg 1999;89:395
© 1999 International Anesthesia Research Society
REGIONAL ANESTHESIA AND PAIN MANAGEMENT
Postoperative Analgesia with No Motor Block by Continuous Epidural Infusion of Ropivacaine 0.1% and Sufentanil After Total Hip Replacement
Sandra Kampe, MD*,
Christoph Weigand, MD*,
Jost Kaufmann*,
Markus Klimek, MD*,
Dietmar Pierre König, MD , and
John Lynch, FFARCSI*
Departments of
*Anesthesiology and
Orthopedic Surgery, University of Cologne, Cologne, Germany
Address correspondence and reprint requests to Sandra Kampe, MD, Department of Anesthesiology, University of Cologne, Joseph-Stelzmann-Straße 9, 50931 Cologne, Germany.
We assessed the analgesic efficacy of postoperative epidural ropivacaine 0.1% with and without sufentanil 1 µg/mL in this prospective, randomized, single-blinded study of 30 ASA physical status IIII patients undergoing elective total hip replacement. Lumbar epidural block using 0.75% ropivacaine was combined with either propofol sedation or general anesthesia for surgery. After surgery, the epidural infusion was commenced. Fifteen patients in each group received either an epidural infusion of 0.1% ropivacaine with 1 µg/mL sufentanil (R+S) or 0.1% ropivacaine without sufentanil (R) at a rate of 59 mL/h. All patients had access to IV piritramide via a patient-controlled analgesia device. The R+S group consumed six times less piritramide over a 48-h infusion period than the R group (median 12.7 vs 73.0 mg; P < 0.001). Motor block was negligible for the study duration in both groups. Patient satisfaction was excellent. The incidence of adverse events, such as nausea, was similar. We conclude that a continuous epidural infusion of 0.1% ropivacaine with 1 µg/mL sufentanil is more effective than ropivacaine alone in treating pain after elective hip replacement without motor block.
Implications: This is the first randomized study comparing the efficacy of the epidural combination of ropivacaine 0.1% and sufentanil 1 µg/mL versus plain ropivacaine 0.1% in treating pain after hip replacement. We found that ropivacaine 0.1% and sufentanil 1 µg/mL led to a sixfold reduction in opioid requirements after total hip replacement by producing a negligible motor block.
This article has been cited by other articles:

|
 |

|
 |
 
P. Panousis, A. R. Heller, T. Koch, and R. J. Litz
Epidural Ropivacaine Concentrations for Intraoperative Analgesia During Major Upper Abdominal Surgery: A Prospective, Randomized, Double-Blinded, Placebo-Controlled Study
Anesth. Analg.,
June 1, 2009;
108(6):
1971 - 1976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Kim, S. B. Nam, M. J. Cho, and Y.-S. Shin
Epidural naloxone reduces postoperative nausea and vomiting in patients receiving epidural sufentanil for postoperative analgesia
Br. J. Anaesth.,
August 1, 2007;
99(2):
270 - 275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kampe, C. Poetter, S. Buzello, H.-M. Wenchel, M. Paul, P. Kiencke, and S.-M. Kasper
Ropivacaine 0.1% with Sufentanil 1 {micro}g/mL Inhibits In Vitro Growth of Pseudomonas Aeruginosa and Does Not Promote Multiplication of Staphylococcus Aureus
Anesth. Analg.,
August 1, 2003;
97(2):
409 - 411.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kampe, P. Kiencke, J. Krombach, K. Cranfield, S. M. Kasper, and C. Diefenbach
Current Practice in Postoperative Epidural Analgesia: A German Survey
Anesth. Analg.,
December 1, 2002;
95(6):
1767 - 1769.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Senard, J. L. Joris, D. Ledoux, P. J. Toussaint, B. Lahaye-Goffart, and M. L. Lamy
A Comparison of 0.1% and 0.2% Ropivacaine and Bupivacaine Combined with Morphine for Postoperative Patient-Controlled Epidural Analgesia After Major Abdominal Surgery
Anesth. Analg.,
August 1, 2002;
95(2):
444 - 449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kampe and F. Singelyn
Extended Femoral Nerve Sheath Block After Total Hip Arthroplasty Response
Anesth. Analg.,
September 1, 2001;
93(3):
804 - 804.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G. Wheatley, S. A. Schug, and D. Watson
Safety and efficacy of postoperative epidural analgesia
Br. J. Anaesth.,
July 1, 2001;
87(1):
47 - 61.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Brodner, N. Mertes, H. Van Aken, T. Mollhoff, M. Zahl, S. Wirtz, M. A. E. Marcus, and H. Buerkle
What Concentration of Sufentanil Should be Combined with Ropivacaine 0.2% wt/vol for Postoperative Patient-Controlled Epidural Analgesia?
Anesth. Analg.,
March 1, 2000;
90(3):
649 - 657.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|